Jonathan Fox
President chez EIDOS THERAPEUTICS, INC.
Fortune : 198 032 $ au 31/03/2024
Profil
Jonathan C.
Fox is currently serving as an Independent Director at Edgewise Therapeutics, Inc., a Director at ML Bio Solutions, Inc., and a Trustee at Lankenau Institute for Medical Research.
He is also the President & Chief Medical Officer at Eidos Therapeutics, Inc. and BridgeBio Pharma, Inc. Previously, he held positions as a Senior Director-Clinical Cardiovascular Research at Merck & Co., Inc., a Director-Clinical Pharmacology at GlaxoSmithKline LLC, and the Chief Medical Officer at MyoKardia, Inc. from 2013 to 2016.
He has also worked as a Consulting Professor at Stanford University, a Clinical Professor at the University of Pennsylvania, and a Consultant at The University of California, San Francisco.
Additionally, he served as the Vice President-Clinical Development at AstraZeneca LP from 2004 to 2012.
Dr. Fox obtained his undergraduate and doctorate degrees from The University of Chicago.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
26/12/2023 | 10 857 ( 0,01% ) | 198 032 $ | 31/03/2024 |
Postes actifs de Jonathan Fox
Sociétés | Poste | Début |
---|---|---|
EIDOS THERAPEUTICS, INC. | President | 01/10/2016 |
EDGEWISE THERAPEUTICS, INC. | Director/Board Member | 02/03/2023 |
BRIDGEBIO PHARMA, INC. | President | - |
ML Bio Solutions, Inc. | Director/Board Member | - |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Director/Board Member | - |
Anciens postes connus de Jonathan Fox
Sociétés | Poste | Fin |
---|---|---|
MYOKARDIA, INC. | Chief Tech/Sci/R&D Officer | 30/09/2016 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Chief Tech/Sci/R&D Officer | 01/01/2012 |
Stanford University | Corporate Officer/Principal | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
░░░░░░░░░░ ░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Jonathan Fox
The University of Chicago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
EDGEWISE THERAPEUTICS, INC. | Health Technology |
BRIDGEBIO PHARMA, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Eidos Therapeutics, Inc.
Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
ML Bio Solutions, Inc. |